ASX (AUD): Fisher & Paykel Healthcare Corporation Limited (FPH)
Last Price
33.80
Today's Change
-0.41 (1.19%)
Day's Change
33.36 - 34.25
Trading Volume
67,678
Market Cap
19 Billion
Shares Outstanding
586 Million
Avg Volume
469,465
Avg Price (50 Days)
33.51
Avg Price (200 Days)
28.17
PE Ratio
160.95
EPS
0.21
Earnings Announcement
28-Nov-2024
Previous Close
34.21
Open
34.17
Day's Range
33.36 - 34.25
Year Range
20.03 - 35.76
Trading Volume
67,737
1 Day Change
-1.20%
5 Day Change
2.77%
1 Month Change
1.26%
3 Month Change
12.85%
6 Month Change
29.16%
Ytd Change
53.29%
1 Year Change
70.79%
3 Year Change
13.65%
5 Year Change
75.31%
10 Year Change
576.00%
Max Change
1290.95%
No result.
Sector: Healthcare - Healthcare
Industry: Medical Instruments & Supplies
Description:
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.